|0.6000||-0.0899||-13.03%||Vol 358.60K||1Y Perf -71.73%|
|Aug 11th, 2022 16:00 DELAYED|
|- -||0.03 5.00%|
|Target Price||4.67||Analyst Rating||Strong Buy 1.29|
|Potential %||678.33||Finscreener Ranking||★★★+ 52.25|
|Insiders Trans % 3/6/12 mo.||-/-/100||Value Ranking||★★★ 51.97|
|Insiders Value % 3/6/12 mo.||-/-/100||Growth Ranking||★★ 46.25|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/100||Income Ranking||— -|
|Price Range Ratio 52W %||7.06||Earnings Rating||Strong Buy|
|Market Cap||40.63M||Earnings Date||4th Aug 2022|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.29|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||394.23K|
|Avg. Monthly Volume||186.53K|
|Avg. Quarterly Volume||313.08K|
Aptinyx Inc. (NASDAQ: APTX) stock closed at 0.6 per share at the end of the most recent trading day (a -13.03% change compared to the prior day closing price) with a volume of 358.60K shares and market capitalization of 40.63M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 43 people. Aptinyx Inc. CEO is Norbert G. Riedel.
The one-year performance of Aptinyx Inc. stock is -71.73%, while year-to-date (YTD) performance is -77.53%. APTX stock has a five-year performance of %. Its 52-week range is between 0.36 and 3.7599, which gives APTX stock a 52-week price range ratio of 7.06%
Aptinyx Inc. currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 0.60, a price-to-sale (PS) ratio of 166.58, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -62.02%, a ROC of -58.53% and a ROE of -71.09%. The company’s profit margin is -%, its EBITDA margin is -7 400.80%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Aptinyx Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.29 for the next earnings report. Aptinyx Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Aptinyx Inc. is Strong Buy (1.29), with a target price of $4.67, which is +678.33% compared to the current price. The earnings rating for Aptinyx Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Aptinyx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Aptinyx Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.33, ATR14 : 0.08, CCI20 : 30.97, Chaikin Money Flow : -0.38, MACD : -0.01, Money Flow Index : 50.85, ROC : 0.00, RSI : 43.27, STOCH (14,3) : 60.53, STOCH RSI : 0.76, UO : 42.56, Williams %R : -39.47), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Aptinyx Inc. in the last 12-months were: Ashish Khanna (Buy at a value of $101 700), Joan W. Miller (Buy at a value of $50 091), Norbert G. Riedel (Buy at a value of $223 000), Robert J. Hombach (Buy at a value of $192 000)
Mon, 16 May 2022 12:35 GMT Analysts Are Bullish on Top Healthcare Stocks: Aptinyx (APTX), Actinium Pharmaceuticals (ATNM)- TipRanks. All rights reserved.
Thu, 24 Mar 2022 14:59 GMT Aptinyx (APTX) Gets a Buy Rating from Leerink Partners- TipRanks. All rights reserved.
Thu, 24 Mar 2022 10:25 GMT Aptinyx (APTX) Gets a Buy Rating from H.C. Wainwright- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.